Asami Mori Selected Research

bilirubin glucuronoside glucuronosyltransferase

7/2014	Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.
11/2004	Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome.
11/2003	A novel missense mutation of the bilirubin UDP-glucuronosyltransferase gene in a Turkish patient with Crigler-Najjar syndrome type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asami Mori Research Topics

Disease

23	Ganglion Cysts (Ganglion) 04/2021 - 08/2009
9	Glaucoma 01/2020 - 08/2009
9	Retinal Diseases 01/2018 - 08/2009
7	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2021 - 08/2009
6	Retinal Degeneration 01/2019 - 11/2010
6	Cataract (Cataracts) 01/2019 - 10/2008
6	Ischemia 04/2018 - 11/2010
5	Hypoxia (Hypoxemia) 01/2020 - 03/2014
4	Retinopathy of Prematurity (Retrolental Fibroplasia) 08/2021 - 02/2016
4	Diabetes Mellitus 03/2021 - 08/2008
4	Hyperglycemia 01/2019 - 06/2009
4	Inflammation (Inflammations) 12/2018 - 08/2009
3	Neoplasms (Cancer) 01/2020 - 12/2012
3	Pathologic Neovascularization 01/2020 - 01/2014
3	Reperfusion Injury 08/2015 - 03/2014
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 08/2014 - 08/2013
3	Hyperalgesia 01/2014 - 12/2012
2	Vascular Diseases (Vascular Disease) 08/2021 - 05/2015
2	Premature Birth (Birth, Premature) 08/2021 - 02/2013
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 01/2011
2	Hyperoxia 12/2016 - 10/2015
2	Hypothyroidism 04/2016 - 11/2008
2	Congenital Hypothyroidism (Cretinism) 04/2016 - 11/2008
2	Wounds and Injuries (Trauma) 10/2013 - 08/2009
2	Neuralgia (Stump Neuralgia) 01/2013 - 12/2012
2	Crigler-Najjar Syndrome 11/2004 - 11/2003
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Uveitis 12/2018
1	Optic Nerve Diseases (Optic Neuropathy) 01/2018
1	Chronic Disease (Chronic Diseases) 01/2018
1	Blindness (Hysterical Blindness) 01/2018
1	Diabetes Complications 01/2018
1	Hyperemia 01/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Thyrotoxicosis 01/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016

Drug/Important Bio-Agent (IBA)

30	Retinaldehyde (Retinal)IBA 08/2021 - 06/2007
25	N-Methylaspartate (NMDA)IBA 04/2021 - 08/2009
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2013
9	Glutamic Acid (Glutamate)FDA Link 01/2018 - 08/2009
6	Vasodilator Agents (Vasodilators)IBA 08/2021 - 06/2007
6	Streptozocin (Streptozotocin)FDA Link 01/2019 - 08/2008
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2018 - 08/2013
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 11/2010
3	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2015 - 06/2009
3	N- (2- chloro- 4- ((6,7- dimethoxy- 4- quinazolinyl)oxy)phenyl)- N'- propylureaIBA 08/2014 - 02/2013
3	bilirubin glucuronoside glucuronosyltransferaseIBA 07/2014 - 11/2003
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2014 - 12/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 12/2012
3	elcatoninIBA 01/2014 - 12/2012
2	ParvalbuminsIBA 04/2021 - 10/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
2	Probucol (Lorelco)FDA Link 01/2019 - 12/2017
2	Drinking WaterIBA 01/2019 - 01/2018
2	Crystallins (Crystallin)IBA 01/2019 - 01/2018
2	Purinergic P2X7 ReceptorsIBA 12/2018 - 06/2015
2	Opioid Receptors (Opioid Receptor)IBA 01/2018 - 10/2017
2	ResveratrolIBA 01/2018 - 09/2011
2	Capsaicin (Zostrix)FDA Link 10/2017 - 06/2014
2	Oxygen (Dioxygen)IBA 12/2016 - 01/2014
2	Dual OxidasesIBA 04/2016 - 11/2008
2	Everolimus FDA Link 01/2015 - 01/2014
2	Sirolimus (Rapamycin)FDA Link 01/2015 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 08/2014 - 08/2013
2	BilirubinIBA 07/2014 - 04/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2013 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 12/2012
2	polyolIBA 01/2012 - 01/2010
2	BradykininIBA 09/2011 - 01/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 04/2010
1	CitrullineIBA 03/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Calbindin 2IBA 04/2019
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2019
1	SugarsIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	LipidsIBA 01/2019
1	AntioxidantsIBA 01/2019
1	EndotoxinsIBA 12/2018
1	coomassie Brilliant BlueIBA 12/2018
1	Neuroprotective AgentsIBA 12/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2018
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2018
1	Iron Chelating AgentsIBA 01/2018
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2018
1	PolyphenolsIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 10/2017
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2017
1	Naloxone (Narcan)FDA LinkGeneric 10/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	CalcineurinIBA 01/2017
1	Kainic Acid (Kainate)IBA 11/2016
1	Apelin ReceptorsIBA 11/2016
1	Thyroglobulin FDA Link 04/2016
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2016

Therapy/Procedure

9	Intravitreal Injections 04/2021 - 01/2013
3	Therapeutics 01/2020 - 01/2011